iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

Core Insights - iCAD, Inc. and RamSoft have formed a strategic partnership to integrate iCAD's ProFound AI Breast Health Suite into RamSoft's RIS/PACS platform, enhancing breast cancer detection capabilities across North America [1][2][3] Company Overview - iCAD, Inc. is a leader in AI-powered cancer detection solutions, with its ProFound Breast Health Suite designed to improve early detection of breast cancer and enhance patient outcomes [7] - RamSoft provides cloud-based RIS/PACS solutions, utilized by over 750 sites globally, focusing on improving radiology workflows and diagnostic accuracy [5] Partnership Details - The collaboration aims to streamline workflows in imaging centers by integrating ProFound AI into RamSoft's existing platforms, starting with Mammolink, a provider of 3D mammography services [2][3] - The ProFound AI Breast Health Suite addresses the challenge of undetected breast cancers, which range from 20% to 40% in traditional screenings, by offering high sensitivity analysis of mammograms [2] Technology and Features - The PowerServer platform, which will host the ProFound AI integration, is FDA 510(k) cleared and IHE compliant, ensuring high standards of quality and regulatory compliance [3] - Features of the PowerServer include customizable layouts, MG CAD Markers support, and digital breast tomosynthesis (DBT) capabilities, all aimed at enhancing diagnostic efficiency [3] Industry Context - The increasing adoption of AI in healthcare is driven by the need for improved diagnostic accuracy and operational efficiency, particularly in breast cancer screening [2]